Chronic Pain and Depression: Why They Occur Together and How Ketamine Addresses Both

The Cycle Most Doctors Don't Talk About

If you live with chronic pain, you've probably heard some version of the pain is making you depressed. If you live with depression, you may have been told that depression can make pain feel worse. Both statements are true. They also badly understate what's happening in your brain and body.

Chronic pain and depression aren't just two conditions that happen to coexist. They're intertwined at the neurobiological level, sharing the same neurotransmitter systems, the same inflammatory pathways, and the same brain circuits. That's why treating one and ignoring the other so often fails. It's also why I pay close attention to ketamine therapy in these patients. It may be the first treatment that reaches both conditions through a single mechanism.

Two Conditions, One Biology

The numbers are striking. Up to 85 percent of patients with chronic pain also carry significant depression. People with depression are three to four times more likely to develop a chronic pain condition. That isn't coincidence. It's biology.

Shared Neurotransmitter Pathways

Both conditions disrupt the same chemical messenger systems. Serotonin and norepinephrine modulate mood and pain perception at the same time, and the descending pain inhibition pathway, the one that helps your brain turn down the volume on pain signals, leans heavily on both. When depression depletes those systems, pain signals travel more freely into conscious awareness. Glutamate, the brain's main excitatory neurotransmitter, sits at the center of both pain processing and mood regulation; too much glutamate activity drives central sensitization (amplified pain signaling) and shows up in treatment-resistant depression. GABA, the main inhibitory neurotransmitter, calms both neural pain circuits and anxiety-related activity, and GABAergic deficits appear in both chronic pain and depressive disorders. The two conditions co-occur far more often than chance would predict, and each one worsens the other's prognosis (Bair et al., 2003).

How Chronic Pain Rewires the Nervous System

Chronic pain isn't just acute pain that has overstayed its welcome. Over months and years, persistent signaling produces physical changes in the spinal cord and brain, a process called central sensitization. The nervous system gets more efficient at generating pain. Its threshold drops, so stimuli that shouldn't hurt start to (allodynia), and ordinary pain gets turned up (hyperalgesia).

Depression speeds all of this up. The stress hormones and inflammatory chemicals that come with depression directly promote central sensitization, and that sets up a loop I see constantly. Pain wears on mood. Low mood raises inflammation and stress hormones. Those in turn make the pain signaling louder, which drags mood down further. Each lap tightens the next. The longer someone has been circling, the harder the loop is to interrupt.

The Inflammation Both Conditions Share

Over the past decade, research has shown that chronic pain and depression both involve real neuroinflammation: activation of the brain's immune cells (microglia) and elevated pro-inflammatory cytokines.

That shared inflammatory state helps explain why the two travel together, and why anti-inflammatory approaches sometimes lift both pain and mood at once. It also hints at why ketamine, which has anti-inflammatory properties on top of its other actions, may be well suited to the pain-depression overlap.

Overlapping Brain Regions

Neuroimaging has mapped a lot of shared territory between chronic pain and depression. The anterior cingulate cortex handles both the emotional component of pain and depressive rumination. The prefrontal cortex is involved in pain modulation, emotional regulation, and the cognitive symptoms of depression. The insular cortex ties bodily sensation to emotional awareness. The amygdala processes threat and the emotional response to both pain and depressive triggers. When one condition keeps these regions chronically activated, they're primed to sustain the other.

Why Treating One Without the Other Often Fails

The conventional system tends to split chronic pain and depression into separate tracks. You see a pain specialist for your back and a psychiatrist for your mood, and each one prescribes for their piece of the problem.

The trouble is structural. Antidepressants alone (SSRIs, SNRIs) may lift mood but often do little for pain; SNRIs like duloxetine have some pain-modulating effect, but they don't address central sensitization or glutamate dysfunction. Opioids can dampen pain for a while, but over time they tend to worsen depression, disrupt sleep architecture, and build dependence. Longer stretches of prescription opioid use have been linked to higher rates of new-onset depression across large patient populations (Scherrer et al., 2016). Physical therapy and exercise help both conditions, yet they're nearly impossible to engage with when depression has stripped away motivation and energy. Cognitive behavioral therapy supports pain coping and mood, but it may not be enough while the underlying neurobiology stays put.

What's needed is a treatment aimed at the shared biology driving both.

How Ketamine Addresses Pain and Depression Simultaneously

Ketamine's mechanism is unusually well placed to break the pain-depression cycle at several points. The deeper neurobiology is in our piece on How Ketamine Works for Treatment-Resistant Depression.

How Ketamine Turns Down Pain Amplification

Ketamine blocks NMDA receptors, a glutamate receptor that sits at the heart of central sensitization. By quieting excessive NMDA activity, it can interrupt the "wind-up" in which pain signals climb higher and higher, reduce allodynia and hyperalgesia, and settle the neuronal hyperexcitability that keeps chronic pain states running.

This is why ketamine has been a pain-medicine tool for decades, long before anyone noticed its antidepressant effect. Anesthesiologists and pain specialists have used sub-anesthetic ketamine for complex pain conditions, including neuropathic pain, complex regional pain syndrome, fibromyalgia, and chronic migraines, and multisociety consensus guidelines (ASRA, AAPM, ASA) now spell out where the evidence for intravenous ketamine in chronic pain is strongest (Cohen et al., 2018).

How Ketamine Resets Mood Circuits

Blocking NMDA receptors sets off a downstream cascade that looks nothing like a traditional antidepressant. A surge of glutamate activates AMPA receptors. AMPA activation drives the release of brain-derived neurotrophic factor (BDNF). BDNF promotes synaptogenesis, the growth of new synaptic connections (Li et al., 2010; Autry et al., 2011). Those new connections restore function in the mood-regulating circuits depression had worn down.

The mood shift can show up within hours to days, rather than the weeks or months a conventional antidepressant asks for. For someone caught in the pain-depression cycle, that head start matters.

How Ketamine Opens a Plasticity Window

Ketamine's biggest contribution to comorbid pain and depression may be its effect on neuroplasticity. Both conditions involve maladaptive neural patterns, circuits that have gotten stuck in dysfunctional loops. Ketamine appears to open a window of heightened plasticity, a stretch when the brain forms new connections more readily. During that window, patients often learn new pain-coping strategies more easily. Ruminative thought patterns loosen their grip. And other therapies, from psychotherapy to physical rehabilitation, tend to land harder than they would otherwise.

Anti-Inflammatory Effects

Emerging research suggests ketamine has direct anti-neuroinflammatory effects, including reduced pro-inflammatory cytokines and modulation of microglial activation. Since neuroinflammation drives both pain and depression, this is one more route through which ketamine may help both at once.

What Treatment Looks Like

At Discreet Ketamine, we treat comorbid chronic pain and depression at home. Every patient starts with a full evaluation, where I look at both the pain condition and the mental health history to decide whether ketamine is appropriate and safe. From there we build a plan, with dosing and session frequency tuned to the pain and the mood together rather than one at a time. I manage the sessions between telehealth visits, tracking side effects and adjusting the schedule as we go. We also spend real time on integration, connecting what surfaces in a session to your broader goals while the plasticity window is open. And we keep measuring both pain and mood, so the plan changes when the results say it should.

Learn more about the full process in our hour-by-hour walkthrough of a first at-home ketamine session.

Who Is a Candidate?

Ketamine for comorbid chronic pain and depression tends to make sense when a few things are true. You have chronic pain that hasn't responded well to conventional treatment. You have depression alongside it, whether it arrived before the pain, after it, or at the same time. You've tried antidepressants without enough improvement on either the mood or the pain side. You want to lean less on opioids, or you'd rather have one treatment reach both problems than run two separate ones. Or your diagnosis is one of the centralized pain states ketamine reaches best: neuropathic pain, fibromyalgia, CRPS, chronic migraines, and related conditions.

For more on chronic pain specifically, see our deep-dive on Ketamine Nasal Spray vs. Spravato for Chronic Pain and Depression. For the antidepressant mechanism, see Why Ketamine Works When 2+ Antidepressants Have Failed.

Taking the First Step

Living with both pain and depression can feel like being stuck inside a machine that keeps feeding itself. The reframe I come back to with patients is that you're not fighting two separate problems. You're fighting one loop with two faces, and that loop is exactly what ketamine is built to interrupt. It isn't a cure-all, and it works best inside a broader plan. But for patients who have run out of other options, it's often the treatment that finally reaches both sides of the problem at once.

Check your eligibility today

Frequently Asked Questions

Why do chronic pain and depression so often occur together?

They share neurobiology. Both conditions involve the same neurotransmitter systems (serotonin, norepinephrine, glutamate, GABA), the same inflammatory pathways (microglial activation, pro-inflammatory cytokines), and overlapping brain circuits (anterior cingulate cortex, prefrontal cortex, insula, amygdala). When one condition is active, it primes the same circuits the other relies on. Up to 85 percent of chronic pain patients experience significant depression; people with depression are 3 to 4 times more likely to develop chronic pain. That overlap reflects shared mechanism, not chance.

Can ketamine treat both pain and depression at the same time?

Yes, that's its central advantage for comorbid patients. Ketamine works through NMDA receptor antagonism (which interrupts central pain sensitization), glutamate modulation (which resets mood circuits via the AMPA-BDNF-mTOR cascade), neuroplasticity promotion (which helps the brain build new patterns to replace stuck dysfunctional ones), and anti-neuroinflammatory effects (which address a shared driver of both conditions). Most other treatments target either pain or mood; ketamine is one of the few that legitimately addresses both through a single mechanism.

What types of chronic pain respond to ketamine therapy?

The strongest evidence is for centralized pain conditions: neuropathic pain (diabetic, post-herpetic, chemotherapy-induced), complex regional pain syndrome (CRPS), fibromyalgia, chronic migraines, and other conditions involving central sensitization. Ketamine has been used in pain medicine for decades. Patients with peripheral structural pain (a slipped disc that hasn't been treated, an active inflammation, an unhealed injury) are less likely to respond; the issue there is mechanical, not centrally sensitized.

How long does ketamine relief from chronic pain last?

It varies. Some patients get weeks of pain relief from a single session; others need a complete induction series of 10 or more sessions over 4 to 8 weeks before pain meaningfully improves; a subset need ongoing maintenance dosing every 4 to 8 weeks to hold their gains. The combination of ketamine plus integrated treatment (gentle movement, sleep restoration, addressing depression in parallel, and structured pain-coping work) tends to produce the most durable results.

Will I have to keep taking opioids if I do ketamine therapy?

Often no, and many comorbid patients use ketamine specifically to reduce or eliminate their opioid use. Ketamine and opioids work through different pain pathways (NMDA vs opioid receptors), so they're compatible during a transition; you don't need to stop opioids to start ketamine. Long-term, many patients find that ketamine plus integrated treatment lowers how much opioid they need. Any opioid taper should be coordinated with your prescribing physician, never abruptly.

Is at-home ketamine appropriate for chronic pain or do I need a clinic?

At-home sublingual ketamine works well for chronic pain in maintenance contexts. For acute pain crisis or initial treatment of severe central-sensitization pain, IV ketamine in a clinic is sometimes the right starting point because of dose precision and continuous monitoring. A common pathway is IV induction in a clinic, then transition to at-home sublingual maintenance once response is established. At Discreet Ketamine, we evaluate every chronic pain patient individually and refer to clinic-based treatment when that's the safer fit.

Can ketamine therapy work if I've tried gabapentin, Lyrica, and antidepressants without relief?

Often yes, and that's exactly the population that tends to respond best. Gabapentin, pregabalin (Lyrica), and SNRIs like duloxetine work through pathways that don't address central sensitization or the glutamate dysfunction that drives a lot of chronic centralized pain. Ketamine reaches a different lever entirely. The fact that you've failed multiple conventional treatments isn't a negative signal; it's the clinical picture for which ketamine has the strongest evidence.

Does ketamine cure the underlying cause of chronic pain?

No, and any provider claiming so is misrepresenting it. Ketamine doesn't repair the underlying tissue damage, nerve injury, or structural problem causing your pain. What it does is interrupt central sensitization, restore neural plasticity, and treat the comorbid depression that amplifies pain perception. For many patients with centralized pain that's been resistant to other treatments, that's enough to meaningfully improve daily function and quality of life. For patients whose pain has a primarily mechanical or surgical cause, ketamine is one tool among several, not a replacement for addressing the structural problem.

References

1. Cohen SP, Bhatia A, Buvanendran A, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Regional Anesthesia and Pain Medicine. 2018;43(5):521-546. PMID: 29870458.
2. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Archives of Internal Medicine. 2003;163(20):2433-2445. PMID: 14609780.
3. Scherrer JF, Salas J, Copeland LA, et al. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations. Annals of Family Medicine. 2016;14(1):54-62. PMID: 26755784.
4. Li N, Lee B, Liu RJ, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329(5994):959-964. PMID: 20724638.
5. Autry AE, Adachi M, Nosyreva E, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature. 2011;475(7354):91-95. PMID: 21677641.
6. Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry. 2018;23(4):801-811. PMID: 29532791.

---

Disclaimer: This blog post is for educational purposes only and does not constitute medical advice. Ketamine therapy is a prescription medical treatment that must be supervised by a licensed healthcare provider. Not everyone is a candidate for ketamine therapy, and individual results vary. Ketamine is not FDA-approved for the treatment of chronic pain or depression in the at-home setting specifically, though it is used off-label under medical supervision. This content is not intended to replace the advice of your pain specialist, psychiatrist, or primary care provider. If you are experiencing a mental health crisis, please call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.